Diminished Ovarian Reserve
Women's Health
2
Pipeline Programs
2
Companies
2
Clinical Trials
1
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
2
Early DiscoveryClinical DevelopmentMarket
On Market (1)
Approved therapies currently available
M&
Competitive Landscape
2 companies ranked by most advanced pipeline stage
M&
Ferring PharmaceuticalsArgentina - Buenos Aires
1 programwhole-genome sequencingN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Merck & Co.Ganirelix acetate
Ferring Pharmaceuticalswhole-genome sequencing
Clinical Trials (2)
Total enrollment: 170 patients across 2 trials
Delayed Start to Ovarian Stimulation
Start: May 2012Est. completion: Sep 201430 patients
Phase 4Terminated
Whole-genome Sequencing Study in Patients With Diminished Ovarian Reserve
Start: Sep 2020Est. completion: Dec 2022140 patients
N/AUnknown
Related Jobs in Women's Health
Senior Medical Science Liaison
Ferring Pharmaceuticals
Bangkok, Thailand
Yesterday
Senior Key Account Manager
Ferring Pharmaceuticals
Bucureşti, Romania
1w ago
Territory Representative - Miami
Caldera Medical
Miami, FL, US
1w ago
Senior Client Solutions Manager
Progyny
New York, New York
1w ago
$85K - $95K/yr
Sales Representative, Women's Health - Charleston, SC
Viatris (2)
Remote
1w ago
$72K - $108K/yr
Sales Representative Gynecological Health
Medtronic
Malaga, Andalucia, Spain
1w ago
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space